Hairy cell leukemia (patient information): Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
{{CMG}}; Jinhui Wu, MD | |||
{{EJ}} | {{EJ}} | ||
Revision as of 14:20, 13 October 2009
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jinhui Wu, MD
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Hairy cell leukemia is one type of B-cell lymphoma. It is a rare disease, about 1,000 people in the United States are diagnosed each year. Patients with Hairy cell leukemia tend to be older in general. The cells are small B lymphocytes with projections coming off them that give them a "hairy" appearance. They are always found in the bone marrow, spleen and circulating in the blood. Usual symptoms include unexplained weight loss, fever, night sweat and so on. Like other Non-Hodgkin lymphoma, biospy may be the best method for diagnosis. For Hairy cell leukemia is slow-growing, some patients may never need treatment. An enlarging spleen or dropping blood counts are the usual reasons to begin treatment. Treatments include radiation therapy, chemotherapy, bone marrow or peripheral blood stem cell transplantation and a combination of them.
-
Hairy cell leukemia -
Hairy cell leukemia bone marrow -
Hairy cell leukemia TEM
